![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | A61K 31/7024 | (2006.01) |
A61P 9/10 | (2006.01) |
(11) | Number of the document | 1446131 |
(13) | Kind of document | T |
(96) | European patent application number | 02787601.0 |
Date of filing the European patent application | 2002-11-07 | |
(97) | Date of publication of the European application | 2004-08-18 |
(45) | Date of publication and mention of the grant of the patent | 2007-05-09 |
(46) | Date of publication of the claims translation | 2007-09-25 |
(86) | Number | PCT/EP2002/012482 |
Date | 2002-11-07 |
(87) | Number | WO 2003/041722 |
Date | 2003-05-22 |
(30) | Number | Date | Country code |
01204323 | 2001-11-13 | EP |
(72) |
LENSING, Anthonie Wilhelmus A., c/o N.V. Organon, NL
|
(73) |
Aspen Global Incorporated,
GBS Plaza, Cnr. La Salette & Royal Roads, Grand Bay,
MU
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Fondaparinukso natrio specifinės dozės panaudojimas ūminių koronarinių sindromų gydymui |
USE OF SPECIFIC DOSE OF FONDAPARINUX SODIUM FOR THE TREATMENT OF ACS |
Payment date | Validity (years) | Amount | |
2021-10-26 | 347.00 EUR |